InMode (INMD) | Stock Overview & Key Data
InMode Performance Comparison
Stock Range
Today's Range
Low: $13.40
High: $13.80
on August 1, 2025
52 Week Range
Low: $13.14
High: $19.85
on June 23, 2025
on November 11, 2024
All-Time High: $99.27 on November 1, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$868.5M
EPS
2.38
P/E Ratio (TTM)
5.77
Forward P/E
6.48
P/B Ratio
1.38
PEG Ratio
6.48
Div. Yield
N/A
ROE
25.91%
Beta
1.956
Debt to Equity
0.97
Financial Highlights
Profitability
Gross Margin
79.97%
Operating Margin
23.93%
Profit Margin
44.50%
Returns and Earnings
Return on Assets (TTM)
9.14%
Return on Equity (TTM)
25.91%
EBITDA
$115.4M
Net Income (TTM)
$178.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$5.77
Quarterly Revenue Growth (YoY)
10.60%
Quarterly Earnings Growth (YoY)
12.30%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| InMode INMD | 868.49M Small-cap | -6.66% | -7.35% | -6.53% | -17.58% | -18.99% | -19.93% | -63.75% | -13.53% |
| Abbott Laboratories ABT | 221.54B Mega-cap | 0.59% | -6.58% | -2.74% | -0.90% | 12.21% | 14.36% | 16.51% | 25.74% |
| Boston Scientific BSX | 155.95B Large-cap | -0.69% | 0.60% | 2.15% | 2.27% | 17.93% | 41.49% | 157.47% | 170.49% |
| UFP Technologies UFPT | 1.75B Small-cap | -6.35% | -10.22% | 6.71% | -16.34% | -7.98% | -28.36% | 154.14% | 406.53% |
| Conmed CNMD | 1.62B Small-cap | 2.63% | -3.29% | -8.57% | -26.57% | -22.36% | -23.85% | -46.10% | -38.46% |
| QuidelOrtho QDEL | 1.54B Small-cap | -16.72% | -23.43% | -18.19% | -46.37% | -49.36% | -45.70% | -75.26% | -91.64% |
Ownership & Short Interest
Insider Ownership
15.35%
Institutional Ownership
70.52%
Shares Short
3M
Short Ratio
1.86
Short % of Shares Outstanding
6.11%
Average 10-Day Volume
1M
Average 90-Day Volume
2M
InMode Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in InMode would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is INMD's 52-week high and low?
- In the last 52 weeks, InMode reached a high of $19.85 (on November 11, 2024) and a low of $13.14 (on June 23, 2025).
- What is the market cap and P/E ratio for INMD?
- Curious about InMode's size and valuation? Its market capitalization stands at 868.49M. When it comes to valuation, the P/E ratio (trailing twelve months) is 5.77, and the forward P/E (looking ahead) is 6.48.
- Does INMD pay dividends? If so, what's the yield?
- As for dividends, InMode isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are InMode's main competitors or similar companies to consider before investing?
When looking at InMode, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT221.54B Healthcare Medical Devices 14.36% 16.51% Boston Scientific
BSX155.95B Healthcare Medical Devices 41.49% 157.47% UFP Technologies
UFPT1.75B Healthcare Medical Devices -28.36% 154.14% Conmed
CNMD1.62B Healthcare Medical Devices -23.85% -46.10% QuidelOrtho
QDEL1.54B Healthcare Medical Devices -45.70% -75.26% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for InMode Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of InMode's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 25.91%, the Debt to Equity ratio from the most recent quarter is 0.97, and its Gross Profit Margin stands at 79.97%.
- What is the recent revenue and earnings growth for INMD?
- Looking at InMode's growth, its revenue over the trailing twelve months (TTM) was $402M. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.60%, and quarterly earnings saw a YoY growth of 12.30%.
- How much of INMD stock is held by insiders and institutions?
- Wondering who owns InMode stock? Company insiders (like executives and directors) hold about 15.35% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 70.52%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.